Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$65.20

0.43 (0.66%)

11:07
11/21/18
11/21
11:07
11/21/18
11:07

Analyst thinks Jana could pressure Exact Sciences to pursue sale, The Deal says

Activist investor Jana Partners recently disclosed that it built a position in Exact Sciences in the third quarter and an analyst that The Deal spoke with suggested that Exact Sciences may want to buy companies and that Jana Partners could expedite that approach. Alternatively, Jana could try to pressure Exact Sciences to sell itself, said the analyst, who was quoted as having said, "It wouldn't surprise me if the company is positioning itself as an eventual takeout candidate," according to contacts.

  • 27

    Nov

  • 30

    Nov

EXAS Exact Sciences
$65.20

0.43 (0.66%)

10/10/18
LEER
10/10/18
NO CHANGE
LEER
Outperform
Exact Sciences pullback on Freenome poster a buying opportunity, says Leerink
Leerink analyst Puneet Souda sees a buying opportunity in shares of Exact Sciences, which are reacting negatively to a competitive liquid biopsy CRC screening poster that was presented yesterday by Freenome at the ongoing American College of Gastroenterology conference. While Souda views Freenome's leadership and team as "extremely competent" compared to CellMax, another company seeking to compete with Exact Sciences, Freenome's test is still in developmental stages and commercialization of a such a test "is a long road," Souda tells investors. The analyst, who is also not ruling out the possibility that Exact Sciences is open to reviewing opportunities in liquid biopsy, keeps an Outperform rating on the stock.
10/30/18
UBSW
10/30/18
NO CHANGE
Target $100
UBSW
Buy
Exact Sciences weakness a buying opportunity, says UBS
UBS analyst Daniel Brennan previewed Q3 results for Exact Sciences (EXAS) and said his positive thesis is focused on Q4 where he hopes to see a meaningful increase in testing frequency as the result of its strategic relationship with Pfizer (PFE). He views Q3 as less important to his thesis and would view any weakness following the report as a buying opportunity. Brennan reiterated his Buy rating and $100 price target on Exact Sciences shares.
10/31/18
ADAM
10/31/18
NO CHANGE
Target $87
ADAM
Buy
Exact Sciences bull case intact following beat and raise, says Canaccord
Canaccord analyst Mark Massaro said the bull case for Exact Sciences (EXAS) remains intact after the company delivered another beat and raise quarterly result. The analyst believes the focus will now turn to how well the Pfizer (PFE) and Exact Sciences sales reps work together in Q4 and beyond. Massaro reiterated his Buy rating and $87 price target on Exact Sciences shares.
10/31/18
JEFF
10/31/18
NO CHANGE
Target $84
JEFF
Buy
Exact Sciences price target raised to $84 from $74 at Jefferies
Jefferies analyst Brandon Couillard raised his price target for Exact Sciences to $84 saying the company "bounced back" in Q3 with a "strong" beat and raise. The quarter signaled that recent operational issues are behind the company and that its momentum is rebounding, Couillard tells investors in a post-earnings research note. He maintains a Buy rating on Exact Sciences.

TODAY'S FREE FLY STORIES

AIMT

Aimmune

$21.57

0.07 (0.33%)

10:49
03/25/19
03/25
10:49
03/25/19
10:49
Recommendations
Aimmune analyst commentary  »

Aimmune news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

BB

BlackBerry

$8.82

-0.38 (-4.13%)

10:45
03/25/19
03/25
10:45
03/25/19
10:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

10:45
03/25/19
03/25
10:45
03/25/19
10:45
General news
U.S. Dallas Fed manufacturing index fell 4.8 points to 8.3 in March »

U.S. Dallas Fed…

10:40
03/25/19
03/25
10:40
03/25/19
10:40
General news
Treasury Option Action: option selling »

Treasury Option Action:…

BAYRY

Bayer

$0.00

(0.00%)

, JNJ

Johnson & Johnson

$136.37

-0.62 (-0.45%)

10:38
03/25/19
03/25
10:38
03/25/19
10:38
Hot Stocks
Bayer, J&J's Janssen settle 'virtually all' Xarelto claims in U.S. for $775M »

Bayer (BAYRY) announced…

BAYRY

Bayer

$0.00

(0.00%)

JNJ

Johnson & Johnson

$136.37

-0.62 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 16

    Apr

  • 25

    Apr

ADM

Archer Daniels

$42.52

-0.09 (-0.21%)

10:38
03/25/19
03/25
10:38
03/25/19
10:38
Hot Stocks
Archer Daniels sees negative impact of $50M-$60M in Q1 from extreme weather »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

10:34
03/25/19
03/25
10:34
03/25/19
10:34
General news
Dallas Fed Mfg Survey General Activity Index data reported »

March Dallas Fed Mfg…

10:33
03/25/19
03/25
10:33
03/25/19
10:33
General news
Stocks slide to start week after Mueller doesn't find evidence of collusion »

News that the Mueller…

ORCL

Oracle

$52.35

-0.44 (-0.83%)

10:30
03/25/19
03/25
10:30
03/25/19
10:30
Options
Bearish option flow in Oracle to start the new trading week »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
03/25/19
03/25
10:30
03/25/19
10:30
General news
Fed funds futures are rallying with strong gains across the curve »

Fed funds futures are…

BIIB

Biogen

$218.36

1.07 (0.49%)

, ESALY

Eisai

$0.00

(0.00%)

10:25
03/25/19
03/25
10:25
03/25/19
10:25
On The Fly
After dropping Alzheimer's trials, Biogen announces $5B repurchase program »

Days after its stock…

BIIB

Biogen

$218.36

1.07 (0.49%)

ESALY

Eisai

$0.00

(0.00%)

LLY

Eli Lilly

$129.35

1.05 (0.82%)

AZN

AstraZeneca

$42.45

-0.13 (-0.31%)

PFE

Pfizer

$41.84

-0.06 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 18

    May

  • 28

    May

GOLD

Barrick Gold

$14.12

0.47 (3.44%)

10:25
03/25/19
03/25
10:25
03/25/19
10:25
Options
Barrick Gold call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWNK

Hostess Brands

$11.91

-0.05 (-0.42%)

, K

Kellogg

$56.65

-0.09 (-0.16%)

10:24
03/25/19
03/25
10:24
03/25/19
10:24
Periodicals
Ferrero, Hostess lead contenders for Kellogg's Keebler, CNBC reports »

Hostess Brands (TWNK) and…

TWNK

Hostess Brands

$11.91

-0.05 (-0.42%)

K

Kellogg

$56.65

-0.09 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

NOK

Nokia

$5.88

-0.0601 (-1.01%)

10:23
03/25/19
03/25
10:23
03/25/19
10:23
Hot Stocks
Nokia announces 5G contract with A1 in Austria »

A1 and Nokia announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

FTDR

Frontdoor

$31.90

-0.88 (-2.68%)

, LPSN

LivePerson

$28.54

0.29 (1.03%)

10:20
03/25/19
03/25
10:20
03/25/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FTDR

Frontdoor

$31.90

-0.88 (-2.68%)

LPSN

LivePerson

$28.54

0.29 (1.03%)

KLDO

Kaleido Biosciences

$13.94

0.04 (0.29%)

FOXA

Fox Corp.

$37.95

-0.68 (-1.76%)

GORO

Gold Resource

$4.08

0.21 (5.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 20

    Jun

AKAM

Akamai

$67.94

-3.24 (-4.55%)

, NUS

Nu Skin

$45.20

-4.15 (-8.41%)

10:20
03/25/19
03/25
10:20
03/25/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

AKAM

Akamai

$67.94

-3.24 (-4.55%)

NUS

Nu Skin

$45.20

-4.15 (-8.41%)

TRUE

TrueCar

$6.25

-0.28 (-4.29%)

TXN

Texas Instruments

$107.33

-2.18 (-1.99%)

ADI

Analog Devices

$104.48

-2.86 (-2.66%)

CAMP

CalAmp

$12.25

-0.03 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Apr

  • 25

    Apr

  • 28

    May

  • 28

    May

RF

Regions Financial

$13.53

-0.09 (-0.66%)

, TAL

TAL Education

$35.81

0.37 (1.04%)

10:20
03/25/19
03/25
10:20
03/25/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

RF

Regions Financial

$13.53

-0.09 (-0.66%)

TAL

TAL Education

$35.81

0.37 (1.04%)

EDU

New Oriental Education

$82.74

3.22 (4.05%)

FBNC

First Bancorp

$33.93

0.37 (1.10%)

MSL

MidSouth Bancorp

$10.40

0.18 (1.76%)

LXRX

Lexicon

$5.74

-0.55 (-8.74%)

HIBB

Hibbett Sports

$22.18

0.52 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 24

    Apr

  • 25

    Apr

CMG

Chipotle

$669.66

-2.34 (-0.35%)

10:17
03/25/19
03/25
10:17
03/25/19
10:17
Hot Stocks
California avocado grower issues recall on Listeria concerns »

Henry Avocado announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
03/25/19
03/25
10:17
03/25/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
03/25/19
03/25
10:16
03/25/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
03/25/19
03/25
10:15
03/25/19
10:15
General news
Dallas Fed Mfg Survey General Activity Index to be reported at 10:30 »

March Dallas Fed Mfg…

MSFT

Microsoft

$117.08

0.03 (0.03%)

10:10
03/25/19
03/25
10:10
03/25/19
10:10
Options
Bullish short-term four-way spread opened in Microsoft »

Bullish short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

  • 04

    Apr

10:10
03/25/19
03/25
10:10
03/25/19
10:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

YVR

Liquid Media

$3.57

0.02 (0.56%)

10:06
03/25/19
03/25
10:06
03/25/19
10:06
Hot Stocks
Liquid Media executes agreement to acquire Open Nuage for $858,750 »

Liquid Media Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$23.55

0.22 (0.94%)

10:05
03/25/19
03/25
10:05
03/25/19
10:05
Options
Macy's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.